An analysis of the Edinburgh revision of the declaration of Helsinki

International Journal of Pharmaceutical Medicine

Volumn 14, Issue 6, 2000, Pages 323-328

  Smith, R N ^a  

^a New England Cottage   (United Kingdom)

Author keywords

Access to best proven treatment; Analysis of changes; Placebo controls; Remaining issues; Revision of the Declaration of Helsinki; Stopping trials

Indexed keywords

PLACEBO;

ARTICLE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN RIGHTS; INFORMED CONSENT; MEDICAL ETHICS; PRIORITY JOURNAL;

EID: 0034494297     PISSN: 13649027     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124363-200012000-00010     Document Type: Article

References (11)

1. Editorial. Revising the Declaration of Helsinki
2. World Medical Association Declaration of Helsinki
3. Commentary. The World Medical Association revises the Declaration of Helsinki
4. Helsinki's new clinical rules: Fewer placebos, more disclosure
5. Panel proposes rules for research abroad
6. Policy and people. World Medical Association strengthens Declaration of Helsinki
7. News. Doctors revise Declaration of Helsinki
8. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues
9. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: Practical issues and specific cases
10. Letter to the Editors. Multiculturality and pharmaceutical ethics
11. Editorial. The Declaration of Helsinki